.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}
03.22.2023
How to Mitigate Risk for Biologics During Fill/Finish Manufacturing
As more biologics move through research and development, the demand for specialized aseptic fill/finish services has steadily...
News & Insights
Emergent CDMO News, Insights & Events
When a company develops, manufactures and delivers vaccines and therapeutics that take on the most serious global health threats, it’s not surprising to see their name in the headlines. And we are honored that for more than 20 years, Emergent has been one of those names. Included below are prominent news and feature stories that profile a range of our accomplishments through the years as well as advancements we’ve made in the technologies, processes and expertise needed to serve as a premier CDMO.
01.18.2023
Facility Spotlight: Winnipeg, Manitoba, Canada
For more than 30 years, our Winnipeg, Manitoba (Canada) site has offered a broad range of expertise for drug substance and drug...
11.30.2022
An Inside Look at Drug Product Manufacturing
Emergent's drug product manufacturing facility in Rockville, MD is home to the groninger® INTEGRA, a state-of-the-art high speed...
11.04.2022
Outsourced Pharma Capacity Update
Did you miss the large molecule Outsourced Pharma Capacity Update last month? Download the ondemand presentation to learn more...
11.02.2022
The Demand for Nanoparticles in Drug Formulation is Rising
Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect...
10.27.2022
SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions
SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...